- Home
- BBUC vs CLVT Comparison
BBUC vs CLVT Comparison
Compare BBUC & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBUC | CLVT |
|---|---|---|
| Founded | 2022 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BBUC | CLVT |
|---|---|---|
| Price | $36.54 | $3.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 98.9K | ★ 5.9M |
| Earning Date | 02-01-2026 | 10-29-2025 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,713,000,000.00 | $2,501,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.52 | $3.04 |
| 52 Week High | $37.89 | $5.74 |
Technical Indicators
Market Signals| Indicator | BBUC | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 58.95 | 44.97 |
| Support Level | $35.45 | $3.28 |
| Resistance Level | $37.00 | $3.59 |
| Average True Range (ATR) | 1.07 | 0.18 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 68.05 | 24.07 |
Price Performance
Historical ComparisonAbout BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.